Combined intravenous pharmacotherapy in the treatment of patients with decompensated congestive heart failure
- 30 June 1991
- journal article
- Published by Elsevier in American Heart Journal
- Vol. 121 (6) , 1879-1886
- https://doi.org/10.1016/0002-8703(91)90080-2
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- Addition of phosphodiesterase inhibitors to adrenergic agents in acutely ill patientsInternational Journal of Cardiology, 1990
- Hemodynamic Effects of Prolonged Intravenous Therapy with Enoximone in Patients with Severe Congestive Heart FailureJournal of Cardiovascular Pharmacology, 1988
- Combined Therapy with Dobutamine and Amrinone in Severe Heart FailureChest, 1987
- Efficacy and safety of sustained (48 hour) intravenous infusions of milrinone in patients with severe congestive heart failure: A multicenter studyJournal of the American College of Cardiology, 1987
- Deficient production of cyclic AMP: pharmacologic evidence of an important cause of contractile dysfunction in patients with end-stage heart failure.Circulation, 1987
- Effect of combined nitroglycerin and dobutamine infusion in left ventricular dysfunctionAmerican Heart Journal, 1983
- Combined hemodynamic effects of dopamine and dobutamine in cardiogenic shock.Circulation, 1983
- Combined vasodilator and inotropic therapy of heart failure: Experimental and clinical conceptsAmerican Heart Journal, 1981
- Hemodynamic Assessment of AmrinoneNew England Journal of Medicine, 1978
- The cardiovascular effects of the continuous infusion of dobutamine in patients with severe cardiac failure.Circulation, 1977